As part of the Healthy Ambition program, Crucell’s operational excellence program, the formulation, filling and packaging of Dukoral in Sweden will stop during 2011 and will move to Spain. The bulk production of Dukoral and rCTB will stop in 2012 and will move to Switzerland.
The Nordic sales and customer Service and distribution activities will continue to operate from Solna in Sweden and research activities will be closed and concentrated in Leiden before year-end 2008.
Other important elements of the program are: product portfolio optimization, process and infrastructure optimization, network rationalization and further integration and streamlining of various functions.
Target savings of E30 million had already been identified and are expected to be achieved by the end of 2009.